Link Cell Therapies
Biotechnology ResearchView the employees at
Link Cell Therapies-
Zeynep Cakir Target Discovery Scientist
-
Top 5%
Darryl Cudia Research Associate II at Link Cell Therapies-
San Leandro, California, United States
-
Rising Star
Janette Sutton Senior Scientist at Link Cell Therapies-
South San Francisco, California, United States
-
Top 10%
Overview
Link Cell Therapies was launched by Stanford founders Robbie Majzner and Crystal Mackall in partnership with investors Samsara BioCapital and Sheatree Capital. The company is developing a best-in-class logic-gate technology to spur a new generation of cell therapies for patients with solid tumors. Link’s “AND” gates require two cancer-associated targets for a CAR T cell to attack cancer cells, thereby providing specificity for killing of tumor cells while sparing healthy tissue. Combined with additional technologies under development, Link will advance a suite of exciting internal therapeutic programs while exploring opportunities for value creation with strategic partners.
-